1 year return (CAGR)
-25.00%
Lipocine Inc Exchange (NASDAQ, USD)
LPCN
2.16
-0.08 (-3.57%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-15.97%
5 year return (CAGR)
14.24%
10 year return (CAGR)
-4.44%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
17.81M
Price/Sales
11.35
Ent value
14.90M
Price/Book
0.82
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
34.97%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.19 |
| Daily high | 2.21 |
| Daily low | 2.12 |
| Daily Volume | 64K |
| All-time high | 20.00 |
| 1y analyst estimate | 6.00 |
| Beta | 0.46 |
| EPS (TTM) | -1.44 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LPCN | S&P500 | |
| Current price drop from All-time high | -89.20% | -0.58% |
| Highest price drop | -98.78% | -56.47% |
| Date of highest drop | 5 May 2023 | 9 Mar 2009 |
| Avg drop from high | -80.77% | -10.68% |
| Avg time to new high | 1616 days | 12 days |
| Max time to new high | 3230 days | 1805 days |
News
